A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache

Clinical trial NCT03971071 · COMPLETED

Trial details

NCT number: NCT03971071
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Migraine Headache

Start date: 2019-10-07
Primary completion: 2022-12-01
Enrollment: 620

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.